Related Experiment Video
Updated: Aug 8, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 4, 2010
The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma
Tamar Uziel1, Frederique Zindy, Charles J Sherr
1Department of Genetics & Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Abstract:
Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate. Although mutations in the Sonic Hedgehog (Shh) signaling pathway occur in 30% of cases, genetic alterations that account for MB formation in most patients have not yet been identified. We recently determined that the cyclin D-dependent kinase inhibitor, p18(Ink4c), is expressed as CGNPs exit the cell cycle, suggesting that this protein might play a central role in arresting the proliferation of these cells and in timing their subsequent migration and differentiation. In mice, disruption of Ink4c collaborates independently with loss of p53 or with inactivation of the gene (Ptc1) encoding the Shh receptor, Patched, to induce MB formation. Whereas loss of both Ink4c alleles is required for MB formation in a p53-null background, Ink4c is haplo-insufficient for tumor suppression in a Ptc(1+/-) background. Moreover, MBs derived from Ptc(1+/-) mice that lack one or two Ink4c alleles retain wild-type p53. Methylation of the INK4C (CDKN2C) promoter and complete loss of p18(INK4C) protein expression were detected in a significant fraction of human MBs again pointing toward a role for INK4C in suppression of MB formation.
Insights
The cyclin-dependent kinase inhibitor p18(Ink4c) plays a crucial role in preventing pediatric medulloblastoma (MB). Loss of p18(Ink4c) function collaborates with other genetic changes to drive MB formation.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Medulloblastoma (MB) is the most common pediatric brain malignancy.
- MB is believed to arise from cerebellar granule cell precursors (CGNPs) that fail to differentiate.
- While Sonic Hedgehog (Shh) pathway mutations are found in 30% of MBs, other genetic drivers remain largely unknown.
Purpose of the Study:
- To investigate the role of p18(Ink4c), a cyclin-dependent kinase inhibitor, in medulloblastoma development.
- To explore the collaborative effects of Ink4c loss with other genetic alterations (p53, Ptc1) in MB formation.
Main Methods:
- Analysis of Ink4c function in mouse models of medulloblastoma.
- Investigating the genetic cooperation between Ink4c, p53, and the Shh pathway receptor Ptc1.
- Examining INK4C promoter methylation and p18(INK4C) protein expression in human MB samples.
Main Results:
- Disruption of Ink4c collaborates with p53 loss or Ptc1 inactivation to induce MB in mice.
- Ink4c loss is required for MB formation in p53-null mice and is haplo-insufficient in a Ptc(1+/-) background.
- Human MBs frequently show INK4C promoter methylation and loss of p18(INK4C) protein, indicating its tumor-suppressive role.
Conclusions:
- p18(Ink4c) functions as a critical tumor suppressor in medulloblastoma.
- Loss of Ink4c function is a significant factor in MB pathogenesis, particularly in conjunction with other genetic alterations.
- INK4C represents a potential therapeutic target for medulloblastoma.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...